See also this year's filing and all EDGAR filings for this company.
PDF Report 0001348911_2018_Kalvista_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001348911, Kalvista Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 34,198,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 97,000 |
| 3 | remainder_Assets | 50,000 |
| 4 | LiabilitiesCurrent | 3,018,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,177,000 |
| 9 | ResearchAndDevelopmentExpense | 12,666,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,504,000 |
| 12 | remainder_NetIncome | 3,736,000 |
| 13 | remainder_ComprehensiveNetIncome | -2,568,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 34,345,000 |
| 1 | Liabilities | 3,018,000 |
| 2 | Expenses | 23,843,000 |
| 3 | Revenues | 1,504,000 |
| 4 | StockholdersEquity | 31,327,000 |
| 5 | NetIncome | -18,603,000 |
| 6 | ComprehensiveNetIncome | -19,887,000 |
| 7 | BaseVar | 34,507,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.59 |
| 9 | EconomicCapitalRatio | 3.42 |